These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11716486)

  • 21. Macrophage paraoxonase 1 (PON1) binding sites.
    Efrat M; Aviram M
    Biochem Biophys Res Commun; 2008 Nov; 376(1):105-10. PubMed ID: 18762170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs.
    Sentí M; Tomás M; Marrugat J; Elosua R;
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):415-20. PubMed ID: 11231922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.
    Vekic J; Kotur-Stevuljevic J; Jelic-Ivanovic Z; Spasic S; Spasojevic-Kalimanovska V; Topic A; Zeljkovic A; Stefanovic A; Zunic G
    Eur J Clin Invest; 2007 Sep; 37(9):715-23. PubMed ID: 17696961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy.
    Li C; Gu Q
    Nephrology (Carlton); 2009 Aug; 14(5):514-20. PubMed ID: 19207863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1.
    Kar S; Patel MA; Tripathy RK; Bajaj P; Pande AH
    Biochim Biophys Acta; 2013 Dec; 1831(12):1714-20. PubMed ID: 23973798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin C attenuates hypochlorite-mediated loss of paraoxonase-1 activity from human plasma.
    Kunes JP; Cordero-Koning KS; Lee LH; Lynch SM
    Nutr Res; 2009 Feb; 29(2):114-22. PubMed ID: 19285602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease.
    Atamer A; Kocyigit Y; Ecder SA; Selek S; Ilhan N; Ecder T; Atamer Y
    J Nephrol; 2008; 21(6):924-30. PubMed ID: 19034878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cysteine substitutions in apolipoprotein A-I primary structure modulate paraoxonase activity.
    Oda MN; Bielicki JK; Berger T; Forte TM
    Biochemistry; 2001 Feb; 40(6):1710-8. PubMed ID: 11327831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
    Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A
    Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
    Quéméneur T; Martin-Nizard F; Kandoussi A; Kyndt X; Vanhille P; Hachulla E; Hatron PY; Fruchart JC; Duriez P; Lambert M
    Semin Arthritis Rheum; 2007 Dec; 37(3):149-55. PubMed ID: 17512573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The function, composition, and particle size of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients.
    Cho KH; Park SH; Park JE; Kim YO; Choi I; Kim JJ; Kim JR
    Clin Biochem; 2008 Jan; 41(1-2):56-64. PubMed ID: 17996200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between HDL oxidation and paraoxonase-1 and paraoxonase-1 gene polymorphisms in families affected by familial combined hyperlipidemia.
    Liu ML; James RW; Ylitalo K; Taskinen MR
    Nutr Metab Cardiovasc Dis; 2004 Apr; 14(2):81-7. PubMed ID: 15242240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism.
    Deakin S; Leviev I; Gomaraschi M; Calabresi L; Franceschini G; James RW
    J Biol Chem; 2002 Feb; 277(6):4301-8. PubMed ID: 11726658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adiponectin is an important determinant of apoA-I catabolism.
    Vergès B; Petit JM; Duvillard L; Dautin G; Florentin E; Galland F; Gambert P
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1364-9. PubMed ID: 16574896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of "free" apoA-I in serum: implications for immunological quantification of HDL and its apoproteins.
    Børresen AL; Berg K
    Artery; 1980; 7(2):139-60. PubMed ID: 7425861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution spectrum of paraoxonase activity in HDL fractions.
    Bergmeier C; Siekmeier R; Gross W
    Clin Chem; 2004 Dec; 50(12):2309-15. PubMed ID: 15459089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HDL subfraction distribution of paraoxonase-1 and its relevance to enzyme activity and resistance to oxidative stress.
    Moren X; Deakin S; Liu ML; Taskinen MR; James RW
    J Lipid Res; 2008 Jun; 49(6):1246-53. PubMed ID: 18314464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic inflammation, intestine, and paraoxonase-1.
    Vakili L; Navab KD; Shabihkhani M; Pourtabatabaei N; Vazirian S; Barseghian Z; Seyedali S; Hough G
    Adv Exp Med Biol; 2014; 824():83-8. PubMed ID: 25038995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The intrinsic factor-vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein.
    Kozyraki R; Fyfe J; Kristiansen M; Gerdes C; Jacobsen C; Cui S; Christensen EI; Aminoff M; de la Chapelle A; Krahe R; Verroust PJ; Moestrup SK
    Nat Med; 1999 Jun; 5(6):656-61. PubMed ID: 10371504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.